Thus, blocking IL-6 using anti-IL-6 antibodies successfully improved the CLP murine model’s survival rate [33], indicating that the SF nanofiber scaffolds potentiate the immunomodulatory function of MSCs, resulting in the reduction of plasma IL-6 levels during polymicrobial sepsis, and lowering mortality in septic mice. The gene discussed is IL6; the disease is Sepsis.